The House resumed from May 22 consideration of the motion that Bill C-368, An Act to amend the Food and Drugs Act (natural health products), be read the second time and referred to a committee.
Blaine Calkins Conservative
Introduced as a private member’s bill. (These don’t often become law.)
Report stage (House), as of Dec. 2, 2024
Subscribe to a feed (what's a feed?) of speeches and votes in the House related to Bill C-368.
This is from the published bill.
This enactment amends the Food and Drugs Act to provide that certain natural health products are not therapeutic products within the meaning of that Act and therefore not subject to the same monitoring regime as other drugs.
All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.
Bill numbers are reused for different bills each new session. Perhaps you were looking for one of these other C-368s:
The House resumed from May 22 consideration of the motion that Bill C-368, An Act to amend the Food and Drugs Act (natural health products), be read the second time and referred to a committee.
Food and Drugs ActPrivate Members' Business
The Deputy Speaker Chris d'Entremont
The House will now proceed to the taking of the deferred recorded division on the motion at second reading stage of Bill C-368 under Private Members' Business.
Food and Drugs ActPrivate Members' Business
The Deputy Speaker Chris d'Entremont
I declare the motion carried. Accordingly, the bill stands referred to the Standing Committee on Health.
(Bill read the second time and referred to a committee)